货号:A177991
同义名:
5-碘代杀结核菌素
/ NSC 113939; 5-ITu
5-Iodotubercidin is a potent inhibitor (IC50 = 26 nM). It also inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | 5-Iodotubercidin (NSC 113939), an ATP mimetic, is a potent adenosine kinase inhibitor with an IC50 of 26 nM. 5-Iodotubercidin facilitates glycogen synthesis in isolated hepatocytes by deactivating phosphorylase and activating glycogen synthase. Furthermore, 5-Iodotubercidin obstructs the activity of several kinases including CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC, and Haspin[1].[2].[3]. |
Animal study | Additionally, 5-Iodotubercidin demonstrated effectiveness in combating bicuculline-induced seizures when administered locally into the prepiriform cortex at a dosage of 1 mL/kg, i.p., highlighting its potential therapeutic applications[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.55mL 0.51mL 0.26mL |
12.75mL 2.55mL 1.27mL |
25.50mL 5.10mL 2.55mL |
CAS号 | 24386-93-4 |
分子式 | C11H13IN4O4 |
分子量 | 392.15 |
SMILES Code | NC1=C2C(N([C@H]3[C@@H]([C@@H]([C@@H](CO)O3)O)O)C=C2I)=NC=N1 |
MDL No. | MFCD00055131 |
别名 | 5-碘代杀结核菌素 ;NSC 113939; 5-ITu; Itu |
运输 | 蓝冰 |
InChI Key | WHSIXKUPQCKWBY-IOSLPCCCSA-N |
Pubchem ID | 97297 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|